Skip to Content

TELA Bio Inc Ordinary Shares TELA

Morningstar Rating
$5.63 +0.08 (1.42%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TELA is trading at a 42% discount.
Price
$5.42
Fair Value
$6.17
Uncertainty
Extreme
1-Star Price
$37.57
5-Star Price
$8.91
Economic Moat
Qgy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TELA is a good fit for your portfolio.

Trading Information

Previous Close Price
$5.55
Day Range
$5.505.65
52-Week Range
$4.2811.50
Bid/Ask
$0.00 / $0.00
Market Cap
$138.78 Mil
Volume/Avg
61,046 / 123,151

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.19
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
227

Comparables

Valuation

Metric
TELA
SIBN
MMSI
Price/Earnings (Normalized)
25.07
Price/Book Value
7.283.803.63
Price/Sales
2.194.383.50
Price/Cash Flow
20.47
Price/Earnings
TELA
SIBN
MMSI

Financial Strength

Metric
TELA
SIBN
MMSI
Quick Ratio
3.338.013.81
Current Ratio
4.239.015.45
Interest Coverage
−7.93−13.528.07
Quick Ratio
TELA
SIBN
MMSI

Profitability

Metric
TELA
SIBN
MMSI
Return on Assets (Normalized)
−54.30%−8.97%9.43%
Return on Equity (Normalized)
−196.29%−12.61%14.77%
Return on Invested Capital (Normalized)
−59.27%−11.78%11.47%
Return on Assets
TELA
SIBN
MMSI
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesYdhwcrblMlnzgn$196.9 Bil
SYK
Stryker CorpGfsvpbcymLqr$136.5 Bil
MDT
Medtronic PLCYzbsfqrMzhvft$115.4 Bil
BSX
Boston Scientific CorpHgjqcvbhjHpvwv$100.9 Bil
EW
Edwards Lifesciences CorpXvnjrcfqhJzxsvp$57.3 Bil
DXCM
DexCom IncFqhmwjphdxFnj$53.8 Bil
ZBH
Zimmer Biomet Holdings IncQwzqdfszcKvxtd$27.2 Bil
ALGN
Align Technology IncCpwncxybcPvjcwpf$24.6 Bil
PHG
Koninklijke Philips NV ADRQyhqpxgkBmkbctg$18.4 Bil
PODD
Insulet CorpTkcgwtptmNxrdhv$11.8 Bil

Sponsor Center